GGrantIndex
← Leaderboards

Richard Castillo

Thomas Jefferson University

$1,839,589
Attributed
$4,562,494
Total exposure
4
Grants
1
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $926.8K · FY201325
$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$4,562,494 · 4

By mechanism

R01$2,361,976 · 1
UH3$1,058,781 · 1
UG3$663,601 · 1
K01$478,136 · 1

Top collaborators

Most similar at Thomas Jefferson University

Same institution · by research overlap

Others in their field

Top investigators on “Image

Research focus

ImageData SetInnovationRadiation TherapyStandard Of CareChestValidationComputer SoftwareImaging ModalityMalignant Neoplasm Of LungCancer PatientDoseMapsSide EffectToxic EffectImproved OutcomeClinically SignificantRadiationClinical CareGenerationsLungClinical TrialsProspectiveRadiation Pneumonitis

Grant awards (22)

Quantitative Lung Function Imaging to Reduce Toxicity for patients treated with Radiation and Immunotherapy$420,407
UH3 · FY2025 · CA
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer$320,465
R01 · FY2025 · CA
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer$30,947
R01 · FY2025 · CA
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer$15,043
R01 · FY2025 · CA
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer$348,431
R01 · FY2024 · CA
Quantitative Lung Function Imaging to Reduce Toxicity for patients treated with Radiation and Immunotherapy$223,430
UH3 · FY2024 · CA
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer$130,633
R01 · FY2024 · CA
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer$28,114
R01 · FY2024 · CA
Quantitative Lung Function Imaging to Reduce Toxicity for patients treated with Radiation and Immunotherapy$414,944
UH3 · FY2023 · CA
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer$394,941
R01 · FY2023 · CA
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer$102,351
R01 · FY2023 · CA
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer$14,549
R01 · FY2023 · CA
Quantitative Lung Function Imaging to Reduce Toxicity for patients treated with Radiation and Immunotherapy$316,568
UG3 · FY2022 · CA
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer$118,825
R01 · FY2022 · CA
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer$383,072
R01 · FY2021 · CA
Quantitative Lung Function Imaging to Reduce Toxicity for patients treated with Radiation and Immunotherapy$347,033
UG3 · FY2021 · CA
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer$75,749
R01 · FY2021 · CA
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer$398,856
R01 · FY2020 · CA
A Bayesian Framework for Inter-Modality Deformable Image Registration Evaluation$119,534
K01 · FY2016 · CA · contact PI
A Bayesian Framework for Inter-Modality Deformable Image Registration Evaluation$119,534
K01 · FY2015 · CA · contact PI
A Bayesian Framework for Inter-Modality Deformable Image Registration Evaluation$119,534
K01 · FY2014 · CA · contact PI
A Bayesian Framework for Inter-Modality Deformable Image Registration Evaluation$119,534
K01 · FY2013 · CA · contact PI